strykerdobe
Hot Topics Subscriber
By Dr. Karen Becker, DVM
www.barkandwhiskers.com
Canine Parvovirus
An 8-week-old puppy in California was diagnosed with this condition on a Friday, received the treatment the same day, was eating again by Saturday evening and was released from the clinic Monday morning.
STORY AT-A-GLANCE
- Canine parvovirus is a highly infectious, life-threatening condition that until recently could only be treated with supportive care
- Veterinary drug manufacturer Elanco recently received a conditional license from the USDA for its canine parvovirus monoclonal antibody (CPMA) therapy; veterinarians are now free to purchase it pending individual state approvals
- An 8-week-old puppy in California was diagnosed with parvo on a Friday, received the CPMA treatment the same day, was eating again by Saturday evening, and was released from the clinic Monday morning
- A study of fecal microbiota transplantation (FMT) to treat parvo in puppies concluded this procedure also significantly reduces mortality rates and recovery time; the study also showed that FMT is a safe procedure with no adverse effects
- Despite its effectiveness, safety, and low cost, FMT isn’t yet a widely used veterinary procedure to treat parvo or other GI-related conditions